Asthma exacerbation - Nursing Case Study
Pathophysiology
• Primary mechanism: Hyperresponsiveness of the airways leads to bronchoconstriction, triggered by allergens or irritants, causing smooth muscle contraction and narrowing of the airways, making breathing difficult.
• Secondary mechanism: Inflammation of the airway mucosa involves the infiltration of immune cells like eosinophils and T-helper 2 lymphocytes, leading to edema and increased mucus production, further obstructing airflow.
• Key complication: Mucus plugs formed from excessive mucus can block air passages, worsening airway obstruction and potentially leading to hypoxemia if not managed promptly.
Patient Profile
Demographics:
45-year-old female, school teacher
History:
• Key past medical history: Asthma diagnosed 15 years ago, seasonal allergies, hypertension
• Current medications: Albuterol inhaler as needed, Lisinopril 10 mg daily, Montelukast 10 mg daily
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Shortness of breath and wheezing
• Key symptoms: Increased shortness of breath over the past three days, wheezing, chest tightness, cough with clear sputum, fatigue
• Vital signs: Temperature 98.9°F, Heart rate 112 bpm, Respiratory rate 26 breaths per minute, Blood pressure 150/92 mmHg, Oxygen saturation 90% on room air
Section 1
As the initial assessment continues, the healthcare team observes that the patient's respiratory distress is not alleviating despite the use of her albuterol inhaler. On auscultation, bilateral wheezing is prominent, and there are diminished breath sounds in the lower lobes, suggesting areas of poor airflow possibly due to mucus plugging. The patient's respiratory rate remains elevated at 28 breaths per minute, and she appears anxious, with accessory muscle use noted. Her oxygen saturation has decreased to 88% on room air, indicating worsening hypoxemia, which prompts the initiation of supplemental oxygen therapy via nasal cannula at 3 liters per minute.
Blood tests reveal an elevated eosinophil count, consistent with an allergic or inflammatory process. The arterial blood gas analysis shows a pH of 7.32, pCO2 of 50 mmHg, and HCO3- of 24 mEq/L, suggesting respiratory acidosis due to inadequate ventilation. The patient's chest X-ray does not show any acute infiltrates, ruling out pneumonia, but highlights hyperinflation of the lungs, a typical finding in asthma exacerbations. These findings, coupled with her history of asthma and allergies, indicate that her condition is likely exacerbated by environmental or allergenic triggers, necessitating a review of her exposure history over the past few days.
Given the persistent symptoms and laboratory findings, the healthcare team considers additional interventions. Intravenous corticosteroids are administered to address the underlying inflammation, while nebulized bronchodilators are given to aid in relieving bronchoconstriction more effectively than her inhaler. Continuous monitoring is vital to assess her response to treatment, with a focus on improving oxygenation and ventilation. The team discusses the need for a possible escalation in care if there is no significant improvement, including potential transfer to a higher level of care or the initiation of non-invasive ventilation to support her breathing. It becomes critical to monitor for signs of fatigue and respiratory failure, which could complicate her recovery.
Section 2
As the healthcare team continues to monitor the patient, they observe that despite the administration of intravenous corticosteroids and nebulized bronchodilators, her respiratory status remains concerning. Her respiratory rate has slightly decreased to 26 breaths per minute, suggesting a partial response to therapy, but her oxygen saturation remains borderline at 91% with supplemental oxygen. The patient continues to use accessory muscles for breathing, and her anxiety persists, indicating ongoing respiratory distress. On auscultation, wheezing is still present, and although slightly improved, breath sounds remain diminished in the lower lobes, raising concerns about persistent mucus plugging and airflow obstruction.
The team decides to conduct a repeat arterial blood gas analysis to evaluate her ventilatory status. The results show a pH of 7.34, pCO2 of 48 mmHg, and HCO3- of 25 mEq/L, indicating a slight improvement in her respiratory acidosis but still reflecting inadequate ventilation. Meanwhile, her complete blood count reveals a further increase in the eosinophil count, reinforcing the suspicion of an ongoing allergic reaction. This prompts a detailed review of her recent history for potential environmental exposures or allergens that might have triggered this exacerbation, such as new household pets, changes in medication, or recent travel.
Given the partial response and persistent symptoms, the healthcare team discusses the need for further intervention. They consider initiating non-invasive positive pressure ventilation (NIPPV) to improve alveolar ventilation and reduce her work of breathing. The possibility of transferring her to a higher level of care is also considered, should her condition fail to stabilize. The focus now shifts to optimizing her treatment regimen and environmental controls to prevent further deterioration, while closely monitoring for signs of fatigue and potential respiratory failure. This strategic approach aims to ensure that any new complications are promptly identified and managed, facilitating her recovery and preventing escalation to more invasive measures.
Section 3
Change in Patient Status:
As the team continues to monitor the patient, they notice a change in her status. Approximately an hour after initiating non-invasive positive pressure ventilation (NIPPV), the patient's respiratory rate has decreased to 22 breaths per minute, providing some relief from her labored breathing. However, despite this improvement, her oxygen saturation remains at 91%, prompting the team to reassess her overall condition. Her heart rate has increased to 118 beats per minute, which could indicate compensatory mechanisms at play or increasing distress. The patient reports feeling slightly less anxious but still complains of tightness in her chest and difficulty taking deep breaths.
A repeat auscultation reveals that while wheezing has marginally decreased, there is still a significant reduction in breath sounds in the lower lobes, suggesting persistent mucus plugging. The presence of tachycardia and borderline saturation despite NIPPV raises concerns about the adequacy of her current treatment and the risk of impending respiratory fatigue. The healthcare team decides to increase the pressure settings on the NIPPV to enhance ventilation and considers the initiation of intravenous magnesium sulfate as an adjunct therapy to help relax the bronchial muscles.
The team also revisits her medication history and recent exposures, uncovering that the patient had recently started using a new laundry detergent with strong fragrances, a potential allergen that could have contributed to her exacerbation. This finding prompts the team to educate the patient and her family about potential environmental triggers and the importance of avoiding known allergens. The team remains vigilant, closely monitoring the patient for any signs of deterioration, and prepares for potential escalation of care should her condition fail to improve with these adjustments.
Section 4
Despite the adjustments made to the patient's treatment plan, her condition does not improve as expected. Approximately two hours after increasing the pressure settings on the NIPPV and administering intravenous magnesium sulfate, the patient's oxygen saturation remains stubbornly at 90%. Her respiratory rate has now increased to 28 breaths per minute, and she continues to experience significant chest tightness, suggesting that the interventions have not achieved the desired effect. Her heart rate has further increased to 124 beats per minute, indicating heightened physiological stress. The healthcare team becomes increasingly concerned about the risk of respiratory failure and decides to perform an arterial blood gas (ABG) analysis to gain deeper insights into her respiratory status.
The ABG results reveal a partial pressure of carbon dioxide (PaCO2) of 50 mmHg, indicating hypercapnia, and a pH of 7.31, pointing to respiratory acidosis. These findings suggest that despite the non-invasive support, the patient's respiratory muscles are likely becoming fatigued, and alveolar ventilation is inadequate. Additionally, her blood lactate levels have elevated to 3.2 mmol/L, a sign that her body is under considerable metabolic stress and beginning to rely on anaerobic metabolism due to insufficient oxygenation. The team recognizes the urgency of the situation and begins to deliberate whether to transition the patient to invasive mechanical ventilation to prevent further deterioration.
In the midst of these developments, the patient's family expresses concern about her worsening condition and inquires about the potential risks and benefits of intubation. The team takes this opportunity to discuss the situation with the family, explaining the clinical rationale for considering mechanical ventilation, its potential complications, and the intended outcomes. They also emphasize the importance of continuing to address environmental triggers and optimizing the patient's long-term asthma management plan once the acute crisis is resolved. As they prepare for possible escalation of care, the team remains attentive to the patient's response to the interventions, ready to act swiftly should her respiratory status decline further.
Section 5
As the healthcare team prepares for the potential need for invasive mechanical ventilation, they closely monitor the patient's condition for any changes that might indicate a further decline or improvement. Approximately thirty minutes after the ABG results, the patient begins to exhibit new symptoms. She develops a productive cough, expectorating thick, tenacious sputum that is pale green in color. This raises concerns about a possible underlying infection exacerbating her asthma. Her temperature has also risen slightly to 38.1°C (100.6°F), suggesting a febrile response that may indicate an infectious process. Blood cultures are promptly ordered to identify any pathogens, and a broad-spectrum antibiotic is initiated empirically to address the potential infection.
Despite these efforts, the patient's respiratory status continues to deteriorate. Her oxygen saturation drops further to 88%, despite the adjustments made to her NIPPV settings. Her respiratory rate has increased to 32 breaths per minute, and she appears more anxious and fatigued, a sign that her body is struggling to meet its oxygen demands. The heart rate remains elevated at 130 beats per minute, and her blood pressure is now slightly hypotensive at 92/60 mmHg. The team interprets these findings as indicative of worsening respiratory distress and possible septic physiology due to the suspected infection.
In light of this progression, the team decides to move forward with intubation and mechanical ventilation to stabilize her respiratory status and prevent imminent respiratory failure. They communicate this plan to the patient and her family, emphasizing the critical nature of these interventions to ensure adequate oxygenation and ventilation. As they prepare for the procedure, the team also considers additional diagnostic evaluations to explore the underlying infectious source, including a chest X-ray and further laboratory studies, to refine and tailor the patient's treatment regimen. This step not only addresses the immediate crisis but also sets the stage for longer-term management once the acute episode is resolved.